Johnson & Johnson
JNJ
$188.87
-$0.18-0.10%
NYSE
| 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 92.15B | 90.63B | 89.33B | 88.82B | 87.70B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 92.15B | 90.63B | 89.33B | 88.82B | 87.70B |
| Cost of Revenue | 29.06B | 28.53B | 27.78B | 27.04B | 26.64B |
| Gross Profit | 63.09B | 62.10B | 61.55B | 61.79B | 61.05B |
| SG&A Expenses | 22.74B | 22.21B | 21.91B | 21.95B | 21.29B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.51B | 67.73B | 66.60B | 66.22B | 64.35B |
| Operating Income | 24.64B | 22.90B | 22.73B | 22.60B | 23.35B |
| Income Before Tax | 31.50B | 27.35B | 26.60B | 16.69B | 17.63B |
| Income Tax Expenses | 6.38B | 4.69B | 4.79B | 2.62B | 2.86B |
| Earnings from Continuing Operations | 25.12K | 22.66K | 21.81K | 14.07K | 14.77K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -83.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.12B | 22.66B | 21.81B | 14.07B | 14.68B |
| EBIT | 24.64B | 22.90B | 22.73B | 22.60B | 23.35B |
| EBITDA | 32.02B | 30.36B | 30.03B | 29.94B | 30.25B |
| EPS Basic | 10.42 | 9.40 | 9.05 | 5.83 | 5.88 |
| Normalized Basic EPS | 6.54 | 6.23 | 6.27 | 6.20 | 6.43 |
| EPS Diluted | 10.36 | 9.35 | 8.99 | 5.79 | 5.84 |
| Normalized Diluted EPS | 6.50 | 6.20 | 6.24 | 6.16 | 6.39 |
| Average Basic Shares Outstanding | 9.65B | 9.65B | 9.65B | 9.65B | 9.99B |
| Average Diluted Shares Outstanding | 9.70B | 9.70B | 9.70B | 9.71B | 10.05B |
| Dividend Per Share | 5.08 | 5.02 | 4.96 | 4.91 | 4.86 |
| Payout Ratio | 48.70% | 53.34% | 54.76% | 84.05% | 79.71% |